simponi - Résultats de recherche

humira solution

abbvie corporation - adalimumab - solution - 80mg - adalimumab 80mg - disease-modifying antirheumatic agents

humira solution

abbvie corporation - adalimumab - solution - 10mg - adalimumab 10mg - disease-modifying antirheumatic agents

humira solution

abbvie corporation - adalimumab - solution - 20mg - adalimumab 20mg - disease-modifying antirheumatic agents

hyrimoz solution

sandoz canada incorporated - adalimumab - solution - 40mg - adalimumab 40mg - disease-modifying antirheumatic agents

hyrimoz solution

sandoz canada incorporated - adalimumab - solution - 40mg - adalimumab 40mg - disease-modifying antirheumatic agents

idacio solution

fresenius kabi canada ltd - adalimumab - solution - 40mg - adalimumab 40mg - disease-modifying antirheumatic agents

idacio solution

fresenius kabi canada ltd - adalimumab - solution - 40mg - adalimumab 40mg - disease-modifying antirheumatic agents

idacio solution

fresenius kabi canada ltd - adalimumab - solution - 40mg - adalimumab 40mg - disease-modifying antirheumatic agents

hyrimoz solution

sandoz canada incorporated - adalimumab - solution - 20mg - adalimumab 20mg - disease-modifying antirheumatic agents

abrilada solution

pfizer canada ulc - adalimumab - solution - 40mg - adalimumab 40mg - disease-modifying antirheumatic agents